NL-OMON25485已完成不适用
Tolerance and safety study of a new paediatric peptide feed.
umico Research B.V.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children requiring a paediatric peptide feed. Some conditions where this is required may include inflammatory bowel disease, short bowel syndrome, pancreas/liver disease, chronic diarrhoea, cystic fibrosis, undiagnosed gut problems, coeliac disease;
- •2. Approximately 8-30 kg in weight;
排除标准
- •1. Unsuitable for infants under 1 year of age;
- •2. Children receiving parenteral nutrition for more than 50% energy requirements;
研究者
相似试验
已完成
不适用
Tolerance and safety study of a new paediatric peptide feedISRCTN48462333umico Research B.V. (Netherlands)24
已完成
不适用
Acceptability study of a new paediatric formulation of Orphacol® (cholic acid) in paediatric patients treated for inborn errors in primary bile acid synthesis due to 3ß-Hydroxy-?5-C27- steroid oxidoreductase deficiency or ?4-3-Oxosteroid-5ß-reductase deficiency.K76.8Other specified diseases of liverDRKS00013645aboratoires CTRS4
进行中（未招募）
1 期
Acceptability study of a new paediatric form of vigabatrin in infants and children with infantile spasms or pharmaco-resistant partial epilepsy.Infantile spasms and pharmaco-resistant partial epilepsyMedDRA version: 18.0Level: PTClassification code 10021750Term: Infantile spasmsSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.0Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-000360-17-FRTARGEO
招募中
2 期
First in patients of a New PET Probe FEDACMalignant tumors(solid tumors)JPRN-jRCTs031220192Tamura Kentaro30
已完成
不适用
First in Human study of a New PET Probe FEDACJPRN-jRCTs031210134Tamura Kentaro10